These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 22122183)

  • 1. Strategies for managing heparin therapy in patients with antiphospholipid antibody syndrome.
    Mehta TP; Smythe MA; Mattson JC
    Pharmacotherapy; 2011 Dec; 31(12):1221-31. PubMed ID: 22122183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiphospholipid syndrome: when does the presence of antiphospholipid antibodies require therapy?
    Devine DV; Brigden ML
    Postgrad Med; 1996 Jun; 99(6):105-8, 113-25. PubMed ID: 8668625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.
    Vandiver JW; Vondracek TG
    Pharmacotherapy; 2012 Jun; 32(6):546-58. PubMed ID: 22531940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin monitoring in acute thrombosis associated with antiphospholipid antibody syndrome.
    Wittkowsky AK; Kino KJ
    Pharmacotherapy; 1995; 15(4):517-21. PubMed ID: 7479207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anesthetic management for a patient with anti-phospholipid antigen syndrome].
    Ando Y; Nagano K; Morita S; Itoh H; Fukushima Y
    Masui; 2009 Aug; 58(8):1007-9. PubMed ID: 19702220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of thrombosis in women with antiphospholipid syndrome.
    Chandramouli NB; Rodgers GM
    Clin Obstet Gynecol; 2001 Mar; 44(1):36-47. PubMed ID: 11219245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation monitoring part 2: Unfractionated heparin and low-molecular-weight heparin.
    Spinler SA; Wittkowsky AK; Nutescu EA; Smythe MA
    Ann Pharmacother; 2005; 39(7-8):1275-85. PubMed ID: 15956240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospholipid inhibitors. State of the art.
    Galli M
    Hamostaseologie; 2011 Nov; 31(4):243-6, 248, 250. PubMed ID: 21881700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of antiphospholipid syndrome in pregnancy.
    Cowchock S
    Lupus; 1998; 7 Suppl 2():S95-7. PubMed ID: 9814682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid syndrome: an evolving story.
    Robertson B; Greaves M
    Blood Rev; 2006 Jul; 20(4):201-12. PubMed ID: 16442679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose unfractionated heparin therapy in a pregnant patient with antiphospolipid syndrome: a case report.
    Ogishima H; Ito S; Tsutsumi A; Sugihara M; Goto D; Matsumoto I; Obata-Yasuoka M; Hamada H; Yoshikawa H; Takahashi H; Murashima A; Sumida T
    Int J Rheum Dis; 2010 Aug; 13(3):e32-5. PubMed ID: 20704608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?
    Pierangeli SS; Erkan D
    Lupus; 2010 Apr; 19(4):475-85. PubMed ID: 20353991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring.
    Vandiver JW; Vondracek TG
    Hosp Pract (1995); 2013 Apr; 41(2):16-24. PubMed ID: 23545756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and management of non-criteria obstetric antiphospholipid syndrome.
    Arachchillage DR; Machin SJ; Mackie IJ; Cohen H
    Thromb Haemost; 2015 Jan; 113(1):13-9. PubMed ID: 25318976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of antiphospholipid syndrome].
    Páramo JA; García R; Rodríguez P; Panizo E; Lecumberri R
    Rev Med Univ Navarra; 2007; 51(4):38-41. PubMed ID: 18303659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.